NCT06426446View on ClinicalTrials.gov

Monitoring Patients With Severe Obesity Treated With Wegovy® Using Connected Device: Real-world Data

NANot yet recruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

June 1, 2024

Primary Completion Date

June 1, 2025

Study Completion Date

June 1, 2025

Conditions

Obesity

Interventions

DEVICE

Withings Body Comp Pro

Withings Body Comp Pro from which the following features will be used: body weight, body composition (fat, muscle and bone mass, cardiovascular health (pulse wave velocity, arterial stiffness, vascular age, standing heart rate), nervous health (electrochemical skin conductance)

Trial Locations (1)

75015

Hôpital européen Georges Pompidou - APHP, Paris

All Listed Sponsors

collaborator

BPIfrance

OTHER

collaborator

Withings

INDUSTRY

lead

Assistance Publique - Hôpitaux de Paris

OTHER

NCT06426446 - Monitoring Patients With Severe Obesity Treated With Wegovy® Using Connected Device: Real-world Data | Biotech Hunter | Biotech Hunter